Equifax (EFX) Offering Possible 15.61% Return Over the Next 3 Calendar Days

Equifax's most recent trend suggests a bullish bias. One trading opportunity on Equifax is a Bull Put Spread using a strike $185.00 short put and a strike $175.00 long put offers a potential 15.61% return on risk over the next 3 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $185.00 by expiration. The full premium credit of $1.35 would be kept by the premium seller. The risk of $8.65 would be incurred if the stock dropped below the $175.00 long put strike price.

The 5-day moving average is moving up which suggests that the short-term momentum for Equifax is bullish and the probability of a rise in share price is higher if the stock starts trending.

The 20-day moving average is moving up which suggests that the medium-term momentum for Equifax is bullish.

The RSI indicator is at 69.92 level which suggests that the stock is neither overbought nor oversold at this time.

To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here


LATEST NEWS for Equifax

Should You Consider Investing Your Money in Equifax Inc. (EFX)?
Thu, 08 Apr 2021 16:52:36 +0000
Dynamo Cougar, a Brazilian investment management firm, published its fourth quarter 2020 investor letter – a copy of which can be downloaded here. A return of 24.3% was recorded by the fund for the full-year 2020, above its IBX and Ibovespa benchmarks that delivered a -12.0% and -13.3% return respectively in the same period. You […]

Why Equifax Stock Rose 12% in March
Thu, 08 Apr 2021 12:41:00 +0000
Equifax (NYSE: EFX) shareholders beat a rising market last month. The boost nearly offset all of the data management and analytics provider's recent losses, although shares are still lower so far in 2021. Equifax bucked the downtrend among peers in the cloud services space thanks to positive news on the acquisition front.

Is EFX Stock A Buy or Sell?
Mon, 05 Apr 2021 17:39:06 +0000
In this article you are going to find out whether hedge funds think Equifax Inc. (NYSE:EFX) is a good investment right now. We like to check what the smart money thinks first before doing extensive research on a given stock. Although there have been several high profile failed hedge fund picks, the consensus picks among […]

Top Industrial Stocks for April 2021
Mon, 29 Mar 2021 18:08:11 +0000
The industrial sector includes companies that produce machinery, equipment, and supplies that are used in construction and manufacturing, as well as those that provide related services. These companies are closely tied to the economy, and their business volume often falls sharply during recessions, though each industrial subsector often performs differently.

Equifax Snaps Up i2verify; Street Sees 21% Upside
Thu, 25 Mar 2021 12:44:06 +0000
Data and analytics provider Equifax has acquired income and employment verification provider i2verify. The acquisition will help Equifax expand its automated verification solutions. Equifax’s (EFX) CEO, Mark W. Begor said, “We continue to invest in unique, differentiated data – establishing Equifax as the clear industry leader in the best position to bring new and differentiated solutions to our customers and their consumers.” Begor further added, “Our ability to integrate new data and drive synergies is powered by our cloud-native capability that only Equifax can provide. This enables rapid adoption and integration of bolt-on M&A and innovation that we can deploy more quickly into the marketplace and drive Equifax growth.” The bulk of the i2verify’s clients are from the healthcare and education industry. The acquisition will augment Equifax’s current services offering through its product, The Work Number. (See Equifax stock analysis on TipRanks) Last month, Needham analyst Kyle Peterson reiterated a Buy rating on the stock and raised its target price to $215 (23.27% upside potential) from $210. Commenting after meeting with Equifax’s management, Peterson said, “we remain positive on EFX’s avenues for growth, particularly within EWS, which we believe has a wide competitive moat and untapped opportunities for growth.” Peterson further added, “Given the strong EWS trends, steady rollout of new products, and focus on acquiring businesses in high growth markets, we believe there could be upside to both our and Street estimates.” Turning to rest of the Street, the stock has a Moderate Buy consensus rating alongside an average analyst price target of $210.50 (20.7% upside potential) based on 3 Buys and 2 Holds. Shares have rallied about 67.7% over the past year. Related News: ViacomCBS Drops 23% After Pricing New $3B Stock Sale CuriosityStream’s 2021 Revenue Outlook Tops Estimates After 4Q Beat Adobe Lifts FY21 Outlook After 1Q Beat; Street Sees 22% Upside More recent articles from Smarter Analyst: Forte Posts Lower-Than-Feared Quarterly Loss; Shares Drop 9.5% Mettler-Toledo Acquires PendoTECH; Street Says Hold Ovintiv Agrees To Sell Eagle Ford Assets For $880 Million, Updates Guidance Celanese To Expand Manufacturing Capacity; Street Says Buy

Related Posts

 

MarketTamer is not an investment advisor and is not registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory Authority. Further, owners, employees, agents or representatives of MarketTamer are not acting as investment advisors and might not be registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory.


This company makes no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email, and makes no representations or warranties concerning said company or entity’s compliance with applicable laws and regulations, including, but not limited to, regulations promulgated by the SEC or the CFTC. The sender of this email may receive a portion of the proceeds from the sale of any products or services offered by a company or entity mentioned or recommended in this email. The recipient of this email assumes responsibility for conducting its own due diligence on the aforementioned company or entity and assumes full responsibility, and releases the sender from liability, for any purchase or order made from any company or entity mentioned or recommended in this email.


The content on any of MarketTamer websites, products or communication is for educational purposes only. Nothing in its products, services, or communications shall be construed as a solicitation and/or recommendation to buy or sell a security. Trading stocks, options and other securities involves risk. The risk of loss in trading securities can be substantial. The risk involved with trading stocks, options and other securities is not suitable for all investors. Prior to buying or selling an option, an investor must evaluate his/her own personal financial situation and consider all relevant risk factors. See: Characteristics and Risks of Standardized Options. The www.MarketTamer.com educational training program and software services are provided to improve financial understanding.


The information presented in this site is not intended to be used as the sole basis of any investment decisions, nor should it be construed as advice designed to meet the investment needs of any particular investor. Nothing in our research constitutes legal, accounting or tax advice or individually tailored investment advice. Our research is prepared for general circulation and has been prepared without regard to the individual financial circumstances and objectives of persons who receive or obtain access to it. Our research is based on sources that we believe to be reliable. However, we do not make any representation or warranty, expressed or implied, as to the accuracy of our research, the completeness, or correctness or make any guarantee or other promise as to any results that may be obtained from using our research. To the maximum extent permitted by law, neither we, any of our affiliates, nor any other person, shall have any liability whatsoever to any person for any loss or expense, whether direct, indirect, consequential, incidental or otherwise, arising from or relating in any way to any use of or reliance on our research or the information contained therein. Some discussions contain forward looking statements which are based on current expectations and differences can be expected. All of our research, including the estimates, opinions and information contained therein, reflects our judgment as of the publication or other dissemination date of the research and is subject to change without notice. Further, we expressly disclaim any responsibility to update such research. Investing involves substantial risk. Past performance is not a guarantee of future results, and a loss of original capital may occur. No one receiving or accessing our research should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, including carefully reviewing any applicable prospectuses, press releases, reports and other public filings of the issuer of any securities being considered. None of the information presented should be construed as an offer to sell or buy any particular security. As always, use your best judgment when investing.